horse...speaking of the #12 horse, did people see the new trial announced today for MMED's next experiment?  None other than "mescaline"!  There it is right in front of us!  All along we've been busy getting FDA approvals and 2:1 ratio'd critical care, confirmatory trials using 179 patients from our FAILED phase 3 effort...who needs it?  The success has done nothing but "cause us to be lame"!

It would have been much easier to avoid all the confusing math and annoying long diviion as it pertained to the $6.6M CAD upfront payment from Baxter being stretched out over 108 furlongs.  Who needs the success, the $1.7M CAD "legacy arrangement" is never an issue if Baxter doesn't take a serious interest in us...put it all in the blender along with $275K CAD for a "Pandemic Eve" erroneous financing withdraw and the entire success just reduces our share price...and significantly! Funny how math is like that..put all the numbers in shake it up and ya never know....somebody might yell Yahtzee! ; - )

I say we give the #12 horse some mescaline and then start treating healthy volunteers looking for an altered state and a happier life.."mescaline", right there in front of the #12 horse all along and we missed our chance.  Oh well, let's stay the course and wait for Dom's old pal 'Simon" to tell us when we are ready to make a forward pass and stop "taking a knee" ; - )

Fun, fun, fun until your parents take you "mesacaline away"...Hey with a value 14 TIMES that of ours, let's not question the strategy...ours appears quite clear.

Looking foward to the AGM, I hope we get to vote, it would be fun to see how impactful a few withholds could make on 99.52% approval ratings...wink wink, ah the independent bored!

"And down the stretch they limp" ; - )

Tom